reglab/housing_qa huggingface dataset:
DC Code § 48-804.03 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8 - Prescription Drug Price Information|Subchapter IV - Enforcement|§ 48-804.03. Inspection of pricing records and practices; cease and desist orders

After reasonable notice, the Office of Consumer Protection may inspect the pricing records and practices of any pharmacy or other person, to assure compliance with this chapter. After appropriate notice and hearing, the Office may, if it finds that any person has violated this chapter, issue a cease and desist order against continued or future violation, and such other orders as may otherwise be within powers of that Office.  (Sept. 10, 1976, D.C. Law 1-81, title IV, § 403, 23 DCR 2460.)  Prior Codifications 1981 Ed., § 33-743. 1973 Ed., § 33-843.
DC Code § 48-832.02 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter II - Transparent Business Practices Among Pharmacy Benefits Managers|§ 48-832.02. Compliance

Compliance with the requirements of this subchapter is required in all contracts between a pharmacy benefits manager and a covered entity entered into in the District of Columbia or by a covered entity in the District of Columbia executed after May 18, 2004.  (May 18, 2004, D.C. Law 15-164, § 202, 51 DCR 3688; Mar. 2, 2007, D.C. Law 16-192, § 5062(d), 53 DCR 6899.)  Effect of Amendments D.C. Law 16-192 substituted “and a covered entity entered into in the District of Columbia or by a covered entity in the District of Columbia” for “and a covered entity”. Emergency Legislation For temporary (90 day) amendment of section, see § 2(c) of AccessRX Act Clarification Emergency Amendment Act of 2006 (D.C. Act 16-370, May 5, 2006, 53 DCR 4059). For temporary (90 day) amendment of section, see § 5062(d) of Fiscal Year 2007 Budget Support Emergency Act of 2006 (D.C. Act 16-477, August 8, 2006, 53 DCR 7068). For temporary (90 day) amendment of section, see § 5062(d) of Fiscal Year 2007 Budget Support Congressional Review Emergency Act of 2006 (D.C. Act 16-499, October 23, 2006, 53 DCR 8845). For temporary (90 day) amendment of section, see § 5062(d) of Fiscal Year 2007 Budget Support Congressional Review Emergency Act of 2007 (D.C. Act 17-1, January 16, 2007, 54 DCR 1165). Temporary Legislation For temporary (225 day) amendment of section, see § 2(c) of AccessRx Act Clarification Temporary Amendment of Act of 2006 (D.C. Law 16-154, September 19, 2006, law notification 53 DCR 7926).
DC Code § 48-832.03 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter II - Transparent Business Practices Among Pharmacy Benefits Managers|§ 48-832.03. Enforcement

A violation of this subchapter is a violation of Chapter 39 of Title 28, for which a fine of not more than $10,000 may be adjudged.  (May 18, 2004, D.C. Law 15-164, § 203, 51 DCR 3688; Mar. 2, 2007, D.C. Law 16-191, § 88(b), 53 DCR 6794.)  Effect of Amendments D.C. Law 16-191 validated a previously made technical correction.
DC Code § 48-833.01 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.01. Requirement to disclose prescription drug marketing costs

A manufacturer or labeler of prescription drugs dispensed in the District that employs, directs, or utilizes marketing representatives in the District shall report marketing costs for prescription drugs in the District. These marketing costs shall be reported to the Department for the purposes of assisting the District in its role as a purchaser of prescription drugs and as an administrator of prescription drug programs, enabling the District to determine the scope of prescription drug marketing costs and their effect on the cost, utilization, and delivery of health care services, and furthering the role of the District as guardian of the public interest.  (May 18, 2004, D.C. Law 15-164, § 301, 51 DCR 3688.)
DC Code § 48-833.02 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.02. Manner of reporting

By July 1st of each year, a manufacturer or labeler of prescription drugs that directly or indirectly distributes prescription drugs for dispensation to residents of the District shall file a report with the Department in the form and manner provided by the Department. The report shall be accompanied by payment of a fee, as set by the Department in rule, to support the work of the Department under this subchapter.  (May 18, 2004, D.C. Law 15-164, § 302, 51 DCR 3688.)  Section References This section is referenced in § 48-833.03.
DC Code § 48-833.03 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.03. Content of annual report by manufacturer or labeler

(a) Except as provided in subsection (b) of this section, the annual report filed pursuant to § 48-833.02 shall include the following information as it pertains to marketing activities conducted within the District in a form that provides the value, nature, purpose, and recipient of the expense: (1) All expenses associated with advertising, marketing, and direct promotion of prescription drugs through radio, television, magazines, newspapers, direct mail, and telephone communications as they pertain to District residents; (2) With regard to all persons and entities licensed to provide health care in the District, including health care professionals and persons employed by them in the District, carriers licensed under Title 31, health plans and benefits managers, pharmacies, hospitals, nursing facilities, clinics, and other entities licensed to provide health care in the District, the following information: (A) All expenses associated with educational or informational programs, materials, and seminars, and remuneration for promoting or participating in educational or informational sessions, regardless of whether the manufacturer or labeler provides the educational or informational sessions or materials; (B) All expenses associated with food, entertainment, gifts valued at more than $25, and anything provided to a health care professional for less than market value; (C) All expenses associated with trips and travel; and (D) All expenses associated with product samples, except for samples that will be distributed free of charge to patients; and (3) The aggregate cost of all employees or contractors of the manufacturer or labeler who directly or indirectly engage in the advertising or promotional activities listed in paragraphs (1) and (2) of this subsection, including all forms of payment to those employees. The cost reported under this paragraph shall reflect only that portion of payment to employees or contractors that pertains to activities within the District or to recipients of the advertising or promotional activities who are residents of or are employed in the District. (b) The following marketing expenses are not subject to the requirements of this subchapter: (1) Expenses of $25 or less; (2) Reasonable compensation and reimbursement for expenses in connection with a bona fide clinical trial of a new vaccine, therapy, or treatment; and (3) Scholarships and reimbursement of expenses for attending a significant educational, scientific, or policy-making conference or seminar of a national, regional, or specialty medical or other professional association if the recipient of the scholarship is chosen by the association sponsoring the conference or seminar.  (May 18, 2004, D.C. Law 15-164, § 303, 51 DCR 3688.)  Section References This section is referenced in § 48-831.02.
DC Code § 48-833.04 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.04. Department reports

By November 30th of each year, the Department shall provide an annual report, providing information in aggregate form, on prescription drug marketing expenses to the Council and the Corporation Counsel. By January 1, 2005, and every 2 years thereafter, the Department shall provide a report to the Council and the Corporation Counsel, providing information in aggregate form, containing an analysis of the data submitted to the Department, including the scope of prescription drug marketing activities and expenses and their effect on the cost, utilization, and delivery of health care services, and any recommendations with regard to marketing activities of prescription drug manufacturers and labelers.  (May 18, 2004, D.C. Law 15-164, § 304, 51 DCR 3688.)
DC Code § 48-833.05 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.05. Confidentiality; public information

Notwithstanding any provision of law to the contrary, information submitted to the Department pursuant to this subchapter is confidential and is not a public record. Data compiled in aggregate form by the Department for the purposes of reporting required by this subchapter is a public record as long as it does not reveal trade information that is protected by District, state, or federal law.  (May 18, 2004, D.C. Law 15-164, § 305, 51 DCR 3688.)
DC Code § 48-833.06 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.06. Penalty

This subchapter may be enforced in a civil action brought by the Corporation Counsel. A manufacturer or labeler that fails to provide a report as required by this subchapter commits a civil violation for which a fine of $1,000 plus costs and attorney’s fees may be adjudged.  (May 18, 2004, D.C. Law 15-164, § 306, 51 DCR 3688.)
DC Code § 48-833.07 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.07. Rulemaking

The Mayor is authorized to issue any rules necessary to implement the provisions of this subchapter.  (May 18, 2004, D.C. Law 15-164, § 307, 51 DCR 3688.)  Delegation of Authority Delegation of Authority Pursuant to D.C. Law 16-62, the AccessRx Act of 2004, see Mayor’s Order 2006-60, June 7, 2006 ( 53 DCR 5322).
DC Code § 48-833.08 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.08. Report

The Department shall report to the committee of the Council having jurisdiction over health and human services matters on or before January 1, 2005 and on or before July 1, 2005 on the assessment of fees on manufacturers and labelers of prescription drugs.  (May 18, 2004, D.C. Law 15-164, § 308, 51 DCR 3688.)
DC Code § 48-833.09 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8A - Affordability of Prescription Drugs — AccessRx Program|Subchapter III - Full Disclosure of Prescription Drug Marketing Costs|§ 48-833.09. Applicability date

This subchapter shall apply as of July 1, 2004.  (May 18, 2004, D.C. Law 15-164, § 309, 51 DCR 3688.)
DC Code § 48-852.01 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8F - Safe Disposal of Unused Pharmaceuticals|Subchapter II - Safe Disposal of Controlled Substances|§ 48-852.01. Definitions. [Repealed]

Repealed.  (Apr. 11, 2019, D.C. Law 22-285, § 2, 66 DCR 1621; Aug. 23, 2021, D.C. Act 24-159, § 7173, 68 DCR 008602.)  Applicability Applicability of D.C. Law 22-285: § 8 of D.C. Law 22-285 provided that the creation of this section by § 2 of D.C. Law 22-285 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
DC Code § 48-852.02 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8F - Safe Disposal of Unused Pharmaceuticals|Subchapter II - Safe Disposal of Controlled Substances|§ 48-852.02. Safe disposal of controlled substances. [Repealed]

Repealed.  (Apr. 11, 2019, D.C. Law 22-285, § 3, 66 DCR 1621; Aug. 23, 2021, D.C. Act 24-159, § 7173, 68 DCR 008602.)  Applicability Applicability of D.C. Law 22-285: § 8 of D.C. Law 22-285 provided that the creation of this section by § 3 of D.C. Law 22-285 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
DC Code § 48-852.03 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8F - Safe Disposal of Unused Pharmaceuticals|Subchapter II - Safe Disposal of Controlled Substances|§ 48-852.03. Collection by law enforcement. [Repealed]

Repealed.  (Apr. 11, 2019, D.C. Law 22-285, § 4, 66 DCR 1621; Aug. 23, 2021, D.C. Act 24-159, § 7173, 68 DCR 008602.)  Applicability Applicability of D.C. Law 22-285: § 8 of D.C. Law 22-285 provided that the creation of this section by § 4 of D.C. Law 22-285 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
DC Code § 48-852.04 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8F - Safe Disposal of Unused Pharmaceuticals|Subchapter II - Safe Disposal of Controlled Substances|§ 48-852.04. Registrants authorized to collect; authorized collection activities. [Repealed]

Repealed.  (Apr. 11, 2019, D.C. Law 22-285, § 5, 66 DCR 1621; Aug. 23, 2021, D.C. Act 24-159, § 7173, 68 DCR 008602.)  Applicability Applicability of D.C. Law 22-285: § 8 of D.C. Law 22-285 provided that the creation of this section by § 5 of D.C. Law 22-285 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
DC Code § 48-852.05 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8F - Safe Disposal of Unused Pharmaceuticals|Subchapter II - Safe Disposal of Controlled Substances|§ 48-852.05. Collection receptacles. [Repealed]

Repealed.  (Apr. 11, 2019, D.C. Law 22-285, § 6, 66 DCR 1621; Aug. 23, 2021, D.C. Act 24-159, § 7173, 68 DCR 008602.)  Applicability Applicability of D.C. Law 22-285: § 8 of D.C. Law 22-285 provided that the creation of this section by § 6 of D.C. Law 22-285 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
DC Code § 48-852.06 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8F - Safe Disposal of Unused Pharmaceuticals|Subchapter II - Safe Disposal of Controlled Substances|§ 48-852.06. Collection receptacles at long-term care facilities. [Repealed]

Repealed.  (Apr. 11, 2019, D.C. Law 22-285, § 7, 66 DCR 1621; Aug. 23, 2021, D.C. Act 24-159, § 7173, 68 DCR 008602.)  Applicability Applicability of D.C. Law 22-285: § 8 of D.C. Law 22-285 provided that the creation of this section by § 7 of D.C. Law 22-285 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
DC Code § 48-852.07 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 8F - Safe Disposal of Unused Pharmaceuticals|Subchapter II - Safe Disposal of Controlled Substances|§ 48-852.07. Applicability. [Repealed]

Repealed.  (Apr. 11, 2019, D.C. Law 22-285, § 8, 66 DCR 1621; Aug. 23, 2021, D.C. Act 24-159, § 7173, 68 DCR 008602.)
DC Code § 48-901.01 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter I - Definitions|§ 48-901.01. [Reserved]

Section References This section is referenced in § 16-2301, § 22-2603.01, § 48-853.01, and § 50-1403.02.
DC Code § 48-902.02 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.02. Nomenclature

The controlled substances listed or to be listed in the schedules in §§ 48-902.04, 48-902.06, 48-902.08, 48-902.10 and 48-902.12 are included by whatever official, common, usual, chemical, or trade name designated.  (Aug. 5, 1981, D.C. Law 4-29, § 202, 28 DCR 3081.)  Prior Codifications 1981 Ed., § 33-512.
DC Code § 48-902.03 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.03. Schedule I tests

The Mayor shall place a substance in Schedule I if the Mayor finds that the substance: (1) Has high potential for abuse; and (2) Has no accepted medical use in treatment in the United States or in the District of Columbia or lacks accepted safety for use in treatment under medical supervision.  (Aug. 5, 1981, D.C. Law 4-29, § 203, 28 DCR 3081.)  Prior Codifications 1981 Ed., § 33-513.
DC Code § 48-902.05 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.05. Schedule II tests

The Mayor shall place a substance in Schedule II if the Mayor finds that: (1) The substance has high potential for abuse; (2) The substance has currently accepted medical use in treatment in the United States or the District of Columbia, or currently accepted medical use, with severe restrictions; and (3) The abuse of the substance may lead to severe psychological or physical dependence.  (Aug. 5, 1981, D.C. Law 4-29, § 205, 28 DCR 3081.)  Prior Codifications 1981 Ed., § 33-515.
DC Code § 48-902.07 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.07. Schedule III tests

The Mayor shall place a substance in Schedule III if the Mayor finds that: (1) The substance has a potential for abuse less than the substances listed in Schedules I and II; (2) The substance has currently accepted medical use in treatment in the United States or the District of Columbia; and (3) The abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.  (Aug. 5, 1981, D.C. Law 4-29, § 207, 28 DCR 3081.)  Prior Codifications 1981 Ed., § 33-517.
DC Code § 48-902.09 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.09. Schedule IV tests

The Mayor shall place a substance in Schedule IV if the Mayor finds that: (1) The substance has a low potential for abuse relative to substances in Schedule III; (2) The substance has currently accepted medical use in treatment in the United States or the District of Columbia; and (3) The abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III.  (Aug. 5, 1981, D.C. Law 4-29, § 209, 28 DCR 3081.)  Prior Codifications 1981 Ed., § 33-519.
DC Code § 48-902.11 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.11. Schedule V tests

The Mayor shall place a substance in Schedule V if the Mayor finds that: (1) The substance has low potential for abuse relative to the controlled substances listed in Schedule IV; (2) The substance has currently accepted medical use in treatment in the United States or the District of Columbia; and (3) The substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV.  (Aug. 5, 1981, D.C. Law 4-29, § 211, 28 DCR 3081.)  Prior Codifications 1981 Ed., § 33-521.
DC Code § 48-902.12 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.12. Schedule V enumerated

The controlled substances listed in this section are included in Schedule V unless and until removed therefrom pursuant to § 48-902.01. (1) Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or salts thereof, which also contains 1 or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone: (A) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams; (B) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams; (C) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams; (D) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams; (E) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; and (F) Not more than 0.5 milligrams of difenopin and not less than 25 micrograms of atropine sulfate per dosage unit; (2) Repealed; (3) Deleted upon adoption of rule in 34 DCMR 4370 on July 10, 1987; (4) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs and their salts, as set forth below: Buprenorphine; (5) Prophylhexedrine; and (6) Pyrovalerone.  (Aug. 5, 1981, D.C. Law 4-29, § 212, 28 DCR 3081; amended by rule, 39 DCR 1882; June 8, 2001, D.C. Law 13-300, § 2(b), 47 DCR 7037.)  Prior Codifications 1981 Ed., § 33-522. Section References This section is referenced in § 7-3002, § 44-1201, § 48-853.01, § 48-902.01, § 48-902.02, and § 48-1004. Effect of Amendments D.C. Law 13-300 repealed par. (2) which had read: “(2) Cannabis;”.
DC Code § 48-902.13 (2021)
2021 District of Columbia Code|Title 48 - Foods and Drugs|Chapter 9 - Controlled Substances Act|Subchapter II - Standards and Schedules|§ 48-902.13. Revising and republishing of schedules

The Mayor shall revise and republish the schedules semiannually for 2 years from August 5, 1981, and thereafter annually. The published schedules may include the brand or trade names of the substances controlled.  (Aug. 5, 1981, D.C. Law 4-29, § 213, 28 DCR 3081.)  Prior Codifications 1981 Ed., § 33-523. Section References This section is referenced in § 1-636.02. Cross References Effective date provisions, see § 1-636.02.